DRUG · COUNSELLING NOTES
Lecanemab
LEQEMBI
Updated
New prescription
indication: _____. IV q2wk; MRI monitoring for ARIA; report headache, confusion, vision change; warned on allergies; AEs: infusion reaction, ARIA, headache; non-pharm: routines, exercise, socializing.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV q2wk; MRI monitoring for ARIA; report headache, confusion, vision change; warned on allergies; AEs: infusion reaction, ARIA, headache; non-pharm: routines, exercise, socializing.